Linezolid versus vancomycin in the treatment of nosocomial pneumonia: Results of multicenter, double-blind trial

Antibiotiki i Khimioterapiya

Volumn 47, Issue 1, 2002, Pages 12-17

  Grudinina, S A ^a   Zubkov, M M ^a   Krotova, L A ^a   Kurdyukova, Yu R ^b   Kutsenko, M A ^c   Marinin, V F ^b   Sidorenko, S V ^a   Sinopalnikov, A I ^d   Solomatin, A S ^b   Sterkhova, G V ^b   Fesenko, O V ^d   Fomina, I G ^b   Chuchalin, A G ^c  

^a National Research Centre of Antibiotics   (Russian Federation)

^b Municipal Clinical Oncologic Hospital No 62   (Russian Federation)

^c Research Institute of Pulmonology   (Russian Federation)

^d Ministry of Defense of the Russian Federation   (Russian Federation)

Author keywords

Antibiotic susceptibility; Linezolid; Nosocomial pneumonia; Pathogens; Vancomycin

Indexed keywords

ACETAMIDE DERIVATIVE; ANTIINFECTIVE AGENT; LINEZOLID; OXAZOLIDINONE DERIVATIVE;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL PNEUMONIA; BACTERIUM; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS INFECTION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL;

ACETAMIDES; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BACTERIA; CROSS INFECTION; DOUBLE-BLIND METHOD; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; OXAZOLIDINONES; PNEUMONIA, BACTERIAL;

EID: 0036049895     PISSN: 02352990     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Baughman R. P., Tapson V., McIvor A. The diagnosis and treatment challenges in nosocomial pneumonia. Diagn Microbiol Infect Dis 1999; 33: 131-139
2. Bergogne-Berezin E., Deere D., Joly-Guillou M. L. Opportunistic nosocomial multiply resistant bacterial infections: their treatment and prevention. J Antimicrob Chemother 1993; 32; Suppl A: 39-47.
3. Blinkhorn R. J. Jr. Hospital-acquired pneumonia. Textbook of pulmonary diseases. / Baum GL, Crapo JD, Celli BR, Karlinsky JB, eds. 6th ed Philadelphia; 1998: 543-560.
4. George D. L. Epidemiology of nosocomial pneumonia in intensive care unit patients. Clin Chest Med 1995; 16; 29-44.
5. Craven D. E., Steger K. A., Barber T. W Preventing nosocomial pneumonia: state of the art and perspectives for the 1990s. Am J Med 1991; 91: Suppl: 3B. 44-53.
6. Tablan O. C., Anderson L. J., Arden N H. et al. Guideline for the prevention of nosocomial pneumonia. Part I. Issues on prevention of nosocomial pneumonia. Infect Control Hosp Epidemiol 1994; 15; 587-627.
7. Horan T. C., White J. W , Jarvis W. R. et al. Nosocomial infection surveillance, 1984. MMWR CDC Surveill Summ 1986; 35: 17-29.
8. Cook D J., Kollef M. H. Risk factors for ICU-acquired pneumonia. JAMA 1998, 279: 1605-1606.
9. Richards M. J., Edwards J. R., Culver D. H., Gaynes R. P. National Nosocomial Infections Surveillance System. Nosocomial infections in medical intensive care units in the United States. Crit Care Med 1999; 27: 887-892.
10. Bonten M. J. M., Weinstein R. A. Bird's-eye view of nosocomial infections in medical ICU: blue bugs, fungi, and device days. Crit Care Med. 1999; 27: 853-854.
11. National Nosocomial Infections Surveillance (NNIS) System report, data summary from October 1986-April 1998. Atlanta: Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention. US Department of Health and Human Services, 1998.
12. Panlilio A. L., Culver D. H., Gaynes R. P. et al. Methicillin-resistant Staphylococcus aureus in US hospitals, 1975-1991. Infect Control Hosp Epidemiol 1992; 13: 582-586.
13. Dornbusch K., King A., Legakis N. Incidence of antibiotic resistance in blood and urine isolates from hospitalized patients: report from a European collaborative study. European Study Group on Antibiotic Resistance (ESGAR). Scand J Infect Dis 1998; 30: 281-288.
14. Fagon J. Y., Maillet J. M., Novara A. Hospital-acquired pneumonia: methicillin resistance and intensive care unit admission. Am J Med 1998; 104: 17S-23S
15. Pujol M., Corbella X., Pena C. et al. Clinical and epiderniological findings in mechanically-ventilated patients with methicillin-resistant Staphylococcus aureus pneumonia. Eur J Clin Microbiol Infect Dis 1998; 17: 622-628.
16. Chen M. L., Chang S. C., Pan H. J. et al. Longitudinal analysis of methicillin-resistant Staphylococcus aureus isolates at a teaching hospital in Taiwan. J Formos Med Assoc 1999; 98: 426-432.
17. Gottlieb T., Mitchell D. The independent evolution of resistance to ciprofloxacin, rifampicin, and fusidic acid in methicillin-resistant Staphylococcus aureus in Australian teaching hospitals (1990-1995). Australian Group for Antimicrobial Resistance (AGAR). J Antimicrob Chemother 1998; 42: 67-73.
18. Rubinstein E., Cammarata S. K., Oliphant T. H., WunderinkR. G., and the Linezolid Nosocomial Pneumonia Study Group. Linezolid (PNU-100766) versus Vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study. Clin. Infect. Dis. 2001; 32: 402-412.
19. Bartlett J. G., O'Keefe P., Tally F. P. et al. Bacteriology of hospital-acquired pneumonia. Arch Intern Med 1986, 146: 868-871.